$5 – $45

Regional Academic Drug Discovery Symposium [Tomorrow's Drugs Today]

Event Information

Share this event

Date and Time

Location

Location

Institute For Life Science Entrepreneurship

1075 Morris Avenue

Union, NJ 07083

View Map

Refund Policy

Refund Policy

Refunds up to 7 days before event

Friends Who Are Going
Event description

Description

Regional Academic Drug Discovery Symposium

Tomorrow’s Drugs Today

Wednesday November 8, 2017

8:30AM - 5PM

Institute for Life Science Entrepreneurship

NJCSTM Building, Kean University

1075 Morris Avenue

Union, NJ 07083

Welcome

Keith Bostian, Ph.D. CEO, Institute for Life Science Entrepreneurship; Dean, NJCSTM Program and Office of Tech Transfer, Kean University

Session 1: Different Models

Tri-I TDI/Bridge Medicines: a novel academic drug discovery and development model

Bruce R. Conway, Ph.D. Director, Rockefeller University and the Tri-Institutional Therapeutic Discovery Institute

Bootstrapping Translational Research in Academia – Rutgers University Experience

David Kimball, Ph.D. Assoc Vice President, Translational Sciences and Research Commercialization, Rutgers University

The Moulder Center for Drug Discovery Research - Integrating the Best of Academia & Industry

Wayne Childers, Ph.D. Assoc Professor, Temple Univ School of Pharmacy & Moulder Center for Drug Discovery Research

Translating Academic Innovation into Commercial Opportunity through LIBH REACH Program

Li Liu, Ph.D. Assistant Director, Business Development, Center for Biotechnology, Stony Brook University

Session 2: Funding Translational Research

Session chair – Vincent Smeraglia, J.D., Executive Director, Office of Research Commercialization, Rutgers University

Peter Alff, Ph.D., Executive in Residence, Kairos Ventures

Stephen Goodman, JD, Co-Founder, Mid-Atlantic Bio Angels

Carolyn Buser-Doepner, Ph.D., VP and Global Head of Discovery Partnerships with Academia, Glaxo Smith Kline R&D

James Golubieski, President, NJ Health Foundation/Foundation Venture Capital Group

Lunch and Poster Session: Topics in Academic Drug Discovery

Accepting poster abstracts with registration

Session 3: Case Studies

Trigriluzole: An SBIR-Derived Clinical Compound for the Treatment of Ataxia and Melanoma

Allen Reitz, Ph.D. CEO, Fox Chase Chemical Diversity Center

CX3CR1 Chemokine Antagonists Halt Metastatic Spreading in Animal Models of Metastasis

Joseph Salvino, Ph.D. Professor, Medicinal Chemistry, The Wistar Institute

ILSE-CTM-ATCC Partnership: The Evolution of an Idea into Products used in Drug Discovery

Tasha Santiago-Rodriguez, Ph.D. Senior Scientist, Institute for Life Science Entrepreneurship

Networking/refreshments

For more information and sponsorship opportunities, please contact Sam Kongsamut, Executive Director, Entrepreneur Center, Institute for Life Science Entrepreneurship at skongsamut@ilsebio.com, 973-937-8115.

Share with friends

Date and Time

Location

Institute For Life Science Entrepreneurship

1075 Morris Avenue

Union, NJ 07083

View Map

Refund Policy

Refunds up to 7 days before event

Save This Event

Event Saved